Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for Zeltiq Aesthetics Inc�
28.07
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 13.30 - 35.90
Open     -
Vol / Avg. 0.00/526,230.00
Mkt cap 1.08B
P/E 174.13
Div/yield     -
EPS 0.16
Shares 38.61M
Beta 0.05
Inst. own 101%
Jul 27, 2015
Q2 2015 ZELTIQ Aesthetics Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 17, 2015
ZELTIQ Aesthetics Inc Annual Shareholders Meeting - 12:00PM EDT - Add to calendar
Jun 10, 2015
ZELTIQ Aesthetics Inc at William Blair Annual Growth Stock Conference - 5:40PM EDT - Add to calendar
Jun 9, 2015
ZELTIQ Aesthetics Inc at Goldman Sachs Healthcare Conference - 6:20PM EDT - Add to calendar
Jun 2, 2015
ZELTIQ Aesthetics Inc at Jefferies Global Healthcare Conference Add to calendar
May 5, 2015
Q1 2015 ZELTIQ Aesthetics Inc Earnings Call - Webcast
May 5, 2015
Q1 2015 ZELTIQ Aesthetics Inc Earnings Release
Mar 12, 2015
ZELTIQ Aesthetics Inc at Barclays Healthcare Conference
Mar 9, 2015
ZELTIQ Aesthetics Inc at ROTH Conference
Mar 3, 2015
Q4 2014 ZELTIQ Aesthetics Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -4.13% 0.88%
Operating margin -3.29% 1.22%
EBITD margin - 2.26%
Return on average assets -8.24% 1.60%
Return on average equity -12.24% 2.30%
Employees 408 -
CDP Score - -

Address

4698 Willow Rd Ste 100
PLEASANTON, CA 94588-2806
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons, and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. The Company has an installed base of 2,175 CoolSculpting systems installed across approximately 1,900 practices across the world. Approximately 972,612 CoolSculpting cycles has been shipped to its customers and distributors.

Officers and directors

Mark J. Foley President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Patrick Williams Chief Financial Officer, Senior Vice President
Age: 42
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Keith Sullivan Senior Vice President of Worldwide Sales
Age: 57
Bio & Compensation  - Reuters
Leonard C. DeBenedictis Chief Technology Officer
Age: 73
Bio & Compensation  - Reuters
Carl H. Lamm Vice President of Operations
Age: 52
Bio & Compensation  - Reuters
Mary M. Fisher Independent Director
Age: 53
Bio & Compensation  - Reuters
Jean M. George Independent Director
Age: 57
Bio & Compensation  - Reuters
D. Keith Grossman Independent Director
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Independent Director
Age: 59
Bio & Compensation  - Reuters